USPatent applicationPatented

Insulin sensitivity maintenance and blood sugar level maintenance formulation for the prevention and treatment of diabetes

Granted 3 Jun 2003 · 1 office action

Assignee: Vitacost.com, Inc.

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Wayne F. Gorsek · Examiner: Herbert J. Lilling · AU 1651 · TC 1600

Application· this page
10/187,613
filed 3 Jul 2002
Publication
Not published
not published
Patent
US 6,572,897
granted 3 Jun 2003

Life of the application

9 dated events
⤢ drag to zoom20022004200620082010201220142016201820202022ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

A composition that contains the most potent combination of nutrients with clinical studies proven to assist in the maintenance of insulin sensitivity and healthy blood sugar levels. The formulation contains essential amounts of Alpha Lipoic Acid, Chromium, Lutein, Bioflavonoids(quercetin and rutin), Mormordica Charantia extract, Corosolic Acid, and Gymnema Sylvestre Extract, as well as other ingredients and healthy filler ingredients.

Description

3 parts
›BACKGROUND OF THE INVENTION

The invention relates to a composition that contains the most potent combination of nutrients with clinical studies proven to assist in the maintenance of insulin sensitivity and healthy blood sugar levels.

The advanced formulation is designed to promote healthy blood sugar levels as people age which is critical to good health.

High levels of blood sugar are associated with adverse affects on our vision, heart/circulation, kidneys and nervous system. This is commonly associated with the disease of diabetes. Individual vitamins, minerals, herbs and antioxidants have been studied for their efficacy at promoting healthy blood sugar and protecting cells from the damage of elevated blood sugar levels. This prevents heart disease and strokes.

It is an object of the present invention to provide an unique formulation which allows individuals improve, maintain and optimize blood sugar levels, and prevent and reverse diabetes and the complications associated therewith.

›SUMMARY OF THE INVENTION

The key to the unique formulation is a combination of specific vitamins, minerals, herbs and nutrients. These essential components in the amounts provided uniquely contribute to improved blood sugar levels and insulin delivery to the cells. The formulation will protect the healthy cells in the body from being damaged by blood glucose. This process is called glycation.

The formulation contains essential amounts of Alpha Lipoic Acid, Chromium, Lutein, Bioflavonoids(quercetin and rutin), Mormordica Charantia extract, Corosolic acid, and Gymnema Sylvestre Extract, as well as other ingredients and healthy filler ingredients. It prevents and reduces the glycosylation of hemoglobin.

Diabetics have a high level of oxidative stress and this formulation reduces the oxidative stress which causes diabetic complications.

The formulation is preferably delivered in capsule form at 8 capsules per day.

›DETAILED DESCRIPTION OF THE INVENTION

The present invention involves a composition for oral ingestion that contains Alpha Lipoic Acid, Chromium, Lutein, Bioflavonoids(quercetin and rutin), Mormordica Charantia extract, Corosolic Acid, and Gymnema Sylvestre Extract, as well as other ingredients and healthy filler ingredients. More specifically, this formulated product is a blood sugar level maintenance and management formulation. This formulation allows for enhanced maintenance of insulin and provides required nutrients to combat heart disease, diabetes and strokes.

In order to secure the desired result the following essential components are provided:

Alpha Lipoic Acid is an essential antioxidant which has free radical quenching properties. Alpha Lipoic Acid functions in both fat and water soluble tissues and provides antioxidant protection for healthy nerves and healthy blood sugar levels (600 mg).

The rare mineral chromium plays a major role in the sensitivity of cells to insulin. Supplementing the diet with chromium can decrease fasting blood glucose levels, improve glucose tolerance, lower insulin levels, and promote healthy cholesterol and triglyceride levels (500 mcg) (50 mcg-5,000 mcg).

Lutein is an antioxidant found naturally occurring fatsoluble pigments in plants. Recent studies indicate that Lutein promotes healthy vision as well as a healthy cardiovascular system (6 mg) (0.6-60 mg).

Bioflavonoids including Quercetin (200 mg) (20 mg-2,000 mg) and Rutin (200 mg) (20 mg-2,000 ng) are also essential for the overall maintenance of healthy levels of blood sugar.

Mormordica Charantia Extract (standardized for 2.5% bitter principles, 0.5% Charantin) (500 mg) (50 mg-5,000 mg) is an essential ingredient from bitter melon a tropical fruit widely cultivated in Asia and south America. The blood sugar lowering of the extract has been established in human clinical trials.

Corosolic Acid (lagerstroemia speciosa 1) is an essential component for blood sugar maintenance (48 mg) (4.8 mg-480 mg).

Gymnema Sylvestre (standardized for 25% Gymnemic acids) (600 mg) (60 mg-6,000 mg).

Additionally, the following Vitamins, Minerals and natural supplement additives are all important for the memory health formulation:

In addition to the key components, other components such as kosher gelatin (capsules), magnesium stearate and silica and cellulose are included.

Controlling Blood sugar levels is a confusing and frustrating effort. Only the formulations described help maintain healthy levels for life. Although the invention has been described primarily in connection with special and preferred embodiments, it will be understood that it is capable of modification without departing from the scope of the invention. The following claims are intended to cover all variations, uses, or adaptations of the of the invention, following, in general the principles thereof and including such departures from the present disclosure as come within known or customary practice in the field to which the invention pertains, or as are obvious to persons skilled in the field.

›Tables in the description — 1
Amount per% daily
servingvalue
Vitamin A (betatene ®)5,000IU100%
(as natural carotenoids
beta carotene, alpha carotene,
lutein, zeaxanthin, cryptoxanthin
and palmitate)
Vitamin C (Ester C ®)1g1,666%
(as magnesium ascorbate)(1,000mg)
Vitamin D3 (as cholecalciferol)400IU100%
Natural Vitamin E500IU1,666%
(as d-alpha tocopherol
succinate, gamma, delta and beta)
Thiamine (Vitamin B1 HCL)200mg13,333%
Riboflavin (Vitamin B2)10mg588%
Niacin (Vitamin B3)100mg500%
Pyridoxine HCL (Vitamin B6)100mg5,000%
Folic Acid (as folacin)800mcg200%
Vitamin B12 (Methylcobalamin)2mg33,332%
Biotin3mg1,000%
Pantothenic Acid100mg1,000%
(Vitamin B5 as d-calcium
pantothenate)
Magnesium (as Ascorbate)68mg17%
(Ester C)
Magnesium (as Citrate)232mg58%
Zinc (as OptiZinc ®)15mg100%
Selenium (Selenomethionine)200mcg285%
Copper (as chelate) (AAC)1mg50%
Manganese (as chelate) (ACC)1mg50%
Chromium (as chromium400mcg417%
polynicotinate)
Molybdenum (as chelate) (ACC)150mcg200%
Coenzyme Q1010mg**
Alpha Lipoic Acid600mg**
Black Pepper (Bioperine ®)5mg**
(piper nigrum) (fruit extract)
Milk Thistle Extract500mg**
Bioflaonoid (Quercetin)200mg**
Bioflavonoid (Rutin)200mg**
Green Tea Extract100mg**
(standardized 98% polyphenols
80% Catechins, 45% EGCG)
Plant Enzymes50mg**
(Amylase 2,000 S KB Cellulase 25
CU, Protease 7,500 HUT,
Lipase 25 FIP and
Lactase 250 ALU)
Inositol200mg**
Inositol (as Hexaniacinate)200mg**
Ginkgo Biloba (Ginkoaceace) (leaves)120mg**
(Standardized 24% ginkgo flavon
glycosides, 6% terpene lactones)
Lutein Extract (from 120 mg6mg**
FloraGLO ®)
L-Taurine100mg**
Mormordica Charantia Extract500mg**
Glucosol48mg**
Gymnema Sylvestre Extract600mg**
(other ingredients: Silica,**
Cellulose, Magnesium
Stearate, and Kosher
Gelatin (Capsule)

Claims as granted

2 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

8 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/385
  • A61K36/27
  • A61K31/555
  • A61K31/07
  • A61K36/42
  • A61K31/352
  • A61K31/7048
USPC · US Patent Classification
424/655

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2002Oct 2002Jan 2003Apr 2003Jul 2003USPTOApplicantNon-final rejectionResponse after non-finalNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
0.9 y
335 days filing → grant
Office actions
1
non-final + final
Responses
1
no RCE
Examiner
Herbert J. Lilling
art unit 1651 · TC 1600
Citations: 8 back · 8 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20022004200620082010201220142016201820202022Owner 1liens, releases & corrections
TitleLienReleasehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock